AI MARKET SCANNING

$FYB.DE

🔒 Europe

FORMYCON AG

🏛️ XETRA (GERMANY) 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +2.29%
MAX GAP RECORD +3.28%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $FYB.DE
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+1.30%
Apr 22, 2026 Earnings Release 2026-04-22 (AFTER CLOSE)
+3.28%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.3%
Bullish Gaps (2)
Bearish Gaps (0)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $FYB.DE

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205, which focuses in the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗